Uniplan Investment Counsel’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,831
Closed -$41.4K – 194
2025
Q4
$41.4K Buy
+1,831
New +$39.8K ﹤0.01% 157

Other funds holding ELAN

Uniplan Investment Counsel's ELAN Position: Q1 2026 in Review

Uniplan Investment Counsel sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 1,831 shares — an estimated $41.4K sold.

Uniplan Investment Counsel first reported a position in ELAN in Q4 2025 and held it in 1 quarter. The position peaked at $41.4K in Q4 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Uniplan Investment Counsel reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Uniplan Investment Counsel sold 1,831 Elanco Animal Health shares in Q1 2026, an estimated $41.4K.
  • Uniplan Investment Counsel first reported a position in Elanco Animal Health in Q4 2025 and held it in 1 quarter.
  • Uniplan Investment Counsel's Elanco Animal Health position peaked at $41.4K in Q4 2025.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.